Secondary pulmonary malignancies requiring interventional bronchoscopic procedures.
Interventional pulmonology
secondary pulmonary malignancy
tracheobronchial system
Journal
Turk gogus kalp damar cerrahisi dergisi
ISSN: 1301-5680
Titre abrégé: Turk Gogus Kalp Damar Cerrahisi Derg
Pays: Turkey
ID NLM: 100887967
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
26
04
2020
accepted:
23
07
2020
entrez:
30
9
2021
pubmed:
1
10
2021
medline:
1
10
2021
Statut:
epublish
Résumé
In this study, we aimed to share our singlecenter experience and to investigate the effect of interventional bronchoscopic procedures on secondary pulmonary malignancies in terms of complications, success, and survival rates. A total of 83 patients (42 males, 41 females; mean age: 57.8±15.2 years; range, 18 to 94 years) with secondary pulmonary malignancies who underwent interventional bronchoscopic procedures between January 2009 and December 2019 were retrospectively reviewed. Data including demographic and clinical characteristics of the patients, complications, and success and survival rates were recorded. The most common secondary pulmonary malignancies were kidney and thyroid tumors with the complaints of cough, shortness of breath, and hemoptysis. The mean duration before the diagnosis was 34.7±52.8 (range, 0.1 to 219.3) months, and the mean survival after the diagnosis were 10±13.1 (range, 0.2 to 44.4) months. A total of 92% of the patients had an airway obstruction of >50% and the interventional bronchoscopic procedures such as argon plasma coagulation, laser, cryo, and mechanical resection were successful in achieving airway patency. Laser application was found to significantly improve survival (p=0.015). Acute complication rate was 8.4% and mortality rate was 0%. In patients with tracheobronchial lesions due to secondary pulmonary malignancies, interventional bronchoscopic procedures, regardless of the stage of the disease, provide rapid palliation in life-threatening symptoms such as dyspnea and hemoptysis due to airway obstruction, prolonging patient"s survival and gain time for additional treatments to take effect for primary disease.
Sections du résumé
BACKGROUND
BACKGROUND
In this study, we aimed to share our singlecenter experience and to investigate the effect of interventional bronchoscopic procedures on secondary pulmonary malignancies in terms of complications, success, and survival rates.
METHODS
METHODS
A total of 83 patients (42 males, 41 females; mean age: 57.8±15.2 years; range, 18 to 94 years) with secondary pulmonary malignancies who underwent interventional bronchoscopic procedures between January 2009 and December 2019 were retrospectively reviewed. Data including demographic and clinical characteristics of the patients, complications, and success and survival rates were recorded.
RESULTS
RESULTS
The most common secondary pulmonary malignancies were kidney and thyroid tumors with the complaints of cough, shortness of breath, and hemoptysis. The mean duration before the diagnosis was 34.7±52.8 (range, 0.1 to 219.3) months, and the mean survival after the diagnosis were 10±13.1 (range, 0.2 to 44.4) months. A total of 92% of the patients had an airway obstruction of >50% and the interventional bronchoscopic procedures such as argon plasma coagulation, laser, cryo, and mechanical resection were successful in achieving airway patency. Laser application was found to significantly improve survival (p=0.015). Acute complication rate was 8.4% and mortality rate was 0%.
CONCLUSION
CONCLUSIONS
In patients with tracheobronchial lesions due to secondary pulmonary malignancies, interventional bronchoscopic procedures, regardless of the stage of the disease, provide rapid palliation in life-threatening symptoms such as dyspnea and hemoptysis due to airway obstruction, prolonging patient"s survival and gain time for additional treatments to take effect for primary disease.
Identifiants
pubmed: 34589255
doi: 10.5606/tgkdc.dergisi.2021.19927
pmc: PMC8462117
doi:
Types de publication
Journal Article
Langues
eng
Pagination
360-369Informations de copyright
Copyright © 2021, Turkish Society of Cardiovascular Surgery.
Déclaration de conflit d'intérêts
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Références
Intern Med. 2011;50(2):135-9
pubmed: 21245638
Lung India. 2019 May-Jun;36(3):212-215
pubmed: 31031341
Medicine (Baltimore). 2017 Jan;96(2):e5612
pubmed: 28079794
J Gastrointest Oncol. 2015 Jun;6(3):E48-51
pubmed: 26029466
J Thorac Dis. 2017 Sep;9(Suppl 10):S1087-S1110
pubmed: 29214067
J Thorac Dis. 2017 Mar;9(Suppl 2):S116-S121
pubmed: 28446974
Turk Gogus Kalp Damar Cerrahisi Derg. 2018 Apr 30;26(2):254-259
pubmed: 32082742
J Thorac Dis. 2016 Oct;8(10):E1168-E1176
pubmed: 27867582
Jpn J Clin Oncol. 2002 Jan;32(1):27-9
pubmed: 11932359
J Thorac Dis. 2015 Dec;7(Suppl 4):S380-8
pubmed: 26807285
BMC Pulm Med. 2018 Mar 13;18(1):46
pubmed: 29534706
Respiration. 2010;80(1):38-58
pubmed: 20090288
J Thorac Oncol. 2011 Jan;6(1):38-42
pubmed: 21150471
Surg Oncol. 2001 Jul-Aug;10(1-2):35-42
pubmed: 11719027
Curr Infect Dis Rep. 2006 May;8(3):207-14
pubmed: 16643772
CA Cancer J Clin. 2019 Sep;69(5):363-385
pubmed: 31184787
Cancers (Basel). 2019 Jul 19;11(7):
pubmed: 31330946
Lung Cancer. 2014 Jun;84(3):222-8
pubmed: 24681280
Tokai J Exp Clin Med. 2017 Jul 20;42(2):79-84
pubmed: 28681367
Yonsei Med J. 2013 Mar 1;54(2):403-9
pubmed: 23364974
Chin Med J (Engl). 2019 Feb;132(4):431-436
pubmed: 30707169
J Thorac Dis. 2017 Aug;9(8):2619-2639
pubmed: 28932570
Ann Cardiothorac Surg. 2018 Mar;7(2):183-196
pubmed: 29707496
Chest. 2015 May;147(5):1282-1298
pubmed: 25358019